Möller, M.; Turzer, S.; Ganchev, G.; Wienke, A.; Schütte, W.; Seliger, B.; Riemann, D.
Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade. Cancers 2022, 14, 3690.
https://doi.org/10.3390/cancers14153690
AMA Style
Möller M, Turzer S, Ganchev G, Wienke A, Schütte W, Seliger B, Riemann D.
Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade. Cancers. 2022; 14(15):3690.
https://doi.org/10.3390/cancers14153690
Chicago/Turabian Style
Möller, Miriam, Steffi Turzer, Georgi Ganchev, Andreas Wienke, Wolfgang Schütte, Barbara Seliger, and Dagmar Riemann.
2022. "Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade" Cancers 14, no. 15: 3690.
https://doi.org/10.3390/cancers14153690
APA Style
Möller, M., Turzer, S., Ganchev, G., Wienke, A., Schütte, W., Seliger, B., & Riemann, D.
(2022). Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade. Cancers, 14(15), 3690.
https://doi.org/10.3390/cancers14153690